Development and validation of a predictive model for postoperative complications in elderly patients with locally advanced esophageal squamous cell carcinoma utilizing the POSSUM system and inflammatory markers - Top-Institutions - MDSpire

Development and validation of a predictive model for postoperative complications in elderly patients with locally advanced esophageal squamous cell carcinoma utilizing the POSSUM system and inflammatory markers

  • By

  • Ying Zhang

  • Haifang Zhu

  • Fujuan Yang

  • Lei Yang

  • January 27, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Geriatric Oncology
    • Esophageal Cancer

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Surgical Oncology
    • Geriatric Oncology
    • Translational Cancer Research

  • #3

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Esophageal Cancer Surgery
    • Oncology Research
    • Geriatric Oncology

  • #4

    The National Cancer Center Hospital
    The National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Surgical Oncology
    • Geriatric Oncology
    • Esophageal Cancer

Original Source(s)

Development and validation of a predictive model for postoperative complications in elderly patients with locally advanced esophageal squamous cell carcinoma utilizing the POSSUM system and inflammatory markers

  • by Ying Zhang, Haifang Zhu, Fujuan Yang, Lei Yang

  • January 27, 2026

Related Content

From Sophie Spitz to Molecular Melanocytoma

How one woman's pioneering research transformed pediatric melanoma diagnosis

The Effect of Initial Versus Sequential Chemoradiotherapy on Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study